The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Automated cell counters helps in accurately counting and analysing cells in a fast and reliable manner. It provides cell viability, cell number, cell morphology and other indicators to characterize cells of interest. This gives information about cell health and function important for research and clinical applications.
Market key trends:
One of the key trends in the automated cell counters market is the integration of microfluidics and lab-on-a-chip technologies. The microfluidic platforms integrated with cell counters are gaining popularity as they minimize reagent consumption and accelerate analysis. The biological samples can be directly introduced into the microfluidic devices for cell staining, mixing, imaging and counting. This leads to automation and high throughput analysis important for research and clinical workflows.
SWOT Analysis
Strength: Automated cell counters provide accurate and reliable cell counting results in a short period of time. It eliminates manual errors and reduces variability between operators.
Weakness: High initial costs associated with automated cell counters can be prohibitive for small labs and research facilities. Periodic maintenance and calibration is also required.
Opportunity: Rising stem cell research and increasing R&D investments in cell-based therapies is driving the demand for automated cell counters. Growing prevalence of chronic diseases is another major growth opportunity.
Threats: Availability of cheaper traditional manual methods can slow the adoption of automated technology in cost-sensitive regions. Trade barriers and stringent regulatory approval processes also pose major threats.
Key Takeaways
The global Automated Cell Counters market is expected to witness high growth, exhibiting CAGR of 7.0% over the forecast period, due to increasing investments in cell-based research. North America is expected to dominate the global market owing to presence of key market players and rising funds for cancer research in the region. The Asia Pacific region is anticipated to exhibit the fastest growth rate during the forecast period driven by growing biopharmaceutical industry, rising cancer incidence and increasing healthcare expenditures.
Regional analysis
North America is expected to account for the largest share of the global automated cell counters market during the forecast period. This is attributed to the presence of major market players and increasing investments in cell-based research in the US. The Asia Pacific region is poised to witness the fastest growth rate owing to rapidly developing healthcare infrastructure, rising medical tourism, and growing focus of international players.
Key players
Key players operating in the Automated Cell Counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan. The major players are focusing on new product launches and expansion strategies to gain a competitive advantage in the market.
